NCT00045708View on ClinicalTrials.gov

A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Adult Anaplastic AstrocytomaAdult Giant Cell GlioblastomaAdult GliosarcomaRecurrent Adult Brain Tumor
Interventions
DRUG

ixabepilone

Given IV

OTHER

pharmacological study

Correlative studies

DRUG

Anticonvulsant

Drugs that induce hepatic Metabolic enzymes

Trial Locations (5)

21287

Johns Hopkins University, Baltimore

27157

Wake Forest University, Winston-Salem

30322

Emory University, Atlanta

44106

Cleveland Clinic, Cleveland

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00045708 - A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas | Biotech Hunter | Biotech Hunter